Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220004563 220015826 1.53 null Palliative (P) 2013-12-23 2013-12-23 Cytarabine Low Dose 99 N 220026310 CYTARABINE
220004564 220001815 null 97.8 Curative (C) 2013-02-14 2013-02-14 LI-1 TRIAL null null 220026312 TRIAL
220004565 220001815 1.69 null Curative (C) 2017-10-02 2017-10-04 AML17 TRIAL N N 220026312 AML17 TRIAL
220004566 220001816 null null Disease modification (D) 2014-10-30 2014-11-09 Cytarabine Low Dose null null 220026318 CYTARABINE
220004567 220001816 null 92.2 Curative (C) null 2013-07-24 AML17 TRIAL N N 220026318 AML17 TRIAL
220004568 220001817 1.67 null null 2017-09-23 2017-09-24 Cytarabine Low Dose 02 N 220026323 CYTARABINE
220004569 220001818 1.57 80 Curative (C) null 2013-07-12 AML17 TRIAL N N 220026325 AML17 TRIAL
220004570 220001819 1.7 88.3 null 2015-01-30 2015-01-31 Cytarabine Low Dose Y null 220026326 CYTARABINE
220004571 220010920 1.67 190.1 Curative (C) 2014-08-04 2014-08-18 AML17 TRIAL null N 220026329 AML17 TRIAL
220004572 220010920 1.64 72 Not known (9) 2013-02-24 2013-03-03 AML17 TRIAL 02 N 220026329 AML17 TRIAL
220004573 220001820 1.8 62.2 Adjuvant (A) 2017-09-06 2017-09-06 AML17 TRIAL Y N 220026332 AML17 TRIAL
220004574 220001821 1.67 52 Curative (C) null 2014-05-11 Trial Unspecified null null 220026333 TRIAL
220004575 220001822 1.77 69.5 null 2013-01-15 2013-01-23 AML17 TRIAL null null 220026335 AML17 TRIAL
220004576 220010921 1.31 77.4 Disease modification (D) 2015-07-16 2015-07-18 Trial Unspecified 01 N 220026338 TRIAL
220004577 220010921 1.85 null Palliative (P) 2016-07-03 2016-07-04 CYTARABINE N N 220026338 CYTARABINE
220004578 220018674 1.85 70 Curative (C) 2015-06-03 2015-06-03 Trial Unspecified Y N 220026352 TRIAL
220004579 220018674 1.84 80 null 2016-07-15 2016-07-20 Cytarabine Low Dose N N 220026352 CYTARABINE
220004580 220001823 1.78 92 Not known (9) 2017-09-19 2017-09-20 AML17 TRIAL 1 N 220026354 AML17 TRIAL
220004581 220001823 1.45 76.3 Not known (9) 2016-07-26 2016-07-26 AML17 TRIAL 1 N 220026354 AML17 TRIAL
220004582 220001823 1.83 83.5 null 2017-03-13 2017-03-13 Cytarabine Low Dose null N 220026354 CYTARABINE
220004583 220001823 1.66 84.6 Curative (C) 2013-03-11 2013-03-14 AML17 TRIAL 01 N 220026354 AML17 TRIAL
220004585 220001824 1.65 86.1 null 2017-10-31 2017-10-31 Cytarabine Low Dose N N 220026364 CYTARABINE
220004586 220001824 1.65 42.9 Palliative (P) null 2014-08-22 CYTARABINE N N 220026364 CYTARABINE
220004587 220001824 1.6 null Disease modification (D) 2016-12-14 2016-12-21 Cytarabine Low Dose N N 220026364 CYTARABINE
220004588 220001824 null null Curative (C) 2017-03-15 2017-03-15 AML17 TRIAL 1 null 220026364 AML17 TRIAL
220004589 220001824 null 74.5 Palliative (P) 2014-12-15 2014-12-15 Cytarabine Low Dose Y null 220026364 CYTARABINE
220004590 220001824 null 85 Palliative (P) 2017-01-29 2017-02-09 Cytarabine low (10to20mg/m2) IV/SC N N 220026364 CYTARABINE
220004591 220021697 1.63 null Curative (C) null 2014-09-16 Cytarabine Low Dose 02 null 220026379 CYTARABINE
220004592 220021982 null 73 Not known (9) 2014-02-17 2014-02-17 Trial Unspecified N N 220026380 TRIAL
220004593 220021982 1.62 69.4 Palliative (P) 2013-08-26 2013-08-26 Trial Unspecified null N 220026380 TRIAL
220004594 220001825 1.64 null Palliative (P) 2015-11-09 2015-11-09 Cytarabine Low Dose 99 N 220026384 CYTARABINE
220004595 220001825 1.59 75 Not known (9) 2017-02-14 2017-02-14 AML17 TRIAL null null 220026384 AML17 TRIAL
220004596 220001826 0 88.95 Curative (C) 2013-01-22 2013-01-26 Trial Unspecified Y null 220026390 TRIAL
220004597 220001826 null 98 Curative (C) 2017-06-18 2017-06-18 AML17 TRIAL 1 null 220026390 AML17 TRIAL
220004599 220010926 1.77 66 Palliative (P) 2014-05-27 2014-05-27 AML17 TRIAL 01 N 220026393 AML17 TRIAL
220004600 220010926 1.62 null Palliative (P) 2017-03-22 2017-03-22 Cytarabine Low Dose 2 N 220026393 CYTARABINE
220004601 220010926 1.67 78 null 2014-05-23 2014-05-23 AML17 TRIAL 01 N 220026393 AML17 TRIAL
220004602 220001828 1.84 104 Palliative (P) 2013-03-30 2013-03-30 CYTARABINE N N 220026400 CYTARABINE
220004603 220001828 1.59 80.8 Curative (C) 2013-04-18 2013-04-19 AML17 TRIAL N N 220026400 AML17 TRIAL
220004604 220001829 null 77 Not known (9) 2017-05-07 2017-05-23 CYTARABINE N N 220026408 CYTARABINE
220004607 220001831 1.59 78 Curative (C) 2014-11-21 2014-11-21 Trial Unspecified Y null 220026416 TRIAL
220004608 220001832 null 114.1 Curative (C) 2015-05-05 2015-05-05 Trial Unspecified Y N 220026418 TRIAL
220004609 220001832 1.71 null Curative (C) 2014-02-02 2014-02-06 AML17 TRIAL 01 N 220026418 AML17 TRIAL
220004610 220001832 null 104.2 Curative (C) 2017-10-26 2017-11-02 AML17 TRIAL Y N 220026418 AML17 TRIAL
220004611 220001832 1.67 58 Curative (C) 2015-01-09 2015-01-13 AML17 TRIAL 02 N 220026418 AML17 TRIAL
220004612 220001833 1.62 63.3 Curative (C) 2014-02-14 2014-02-14 AML17 TRIAL 01 N 220026427 AML17 TRIAL
220004613 220001833 1.9 93.6 Curative (C) 2017-10-06 2017-10-06 Trial Unspecified 1 null 220026427 TRIAL
220004614 220001833 1.64 null Curative (C) 2014-01-19 2014-01-21 Trial Unspecified Y N 220026427 TRIAL
220004615 220001833 1.63 73.4 Palliative (P) 2015-01-08 2015-01-14 Trial Unspecified N N 220026427 TRIAL
220004616 220001833 1.56 null Palliative (P) 2015-10-08 2015-10-08 Cytarabine Low Dose null N 220026427 CYTARABINE